TuHURA Biosciences (HURA) Cash from Financing Activities (2011 - 2026)

TuHURA Biosciences' Cash from Financing Activities history runs 16 years deep, the most recent figure standing at $7.1 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities rose 1403.21% year-over-year to $7.1 million; the TTM figure through Mar 2026 stood at $27.6 million (down 54.65% YoY), while the FY2025 annual figure was $19.9 million, down 33.07% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at $7.1 million, up from $6.5 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $33.3 million in Q3 2024, with the low at -$11.8 million in Q2 2023.
• The 5-year median for Cash from Financing Activities is $1.9 million (2022), against an average of $5.4 million.
• The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities jumped 1664519.0% in 2024, then tumbled 105.18% in 2025.
• TuHURA Biosciences' Cash from Financing Activities stood at $1.9 million in 2022, then plunged by 56.61% to $806249.0 in 2023, then soared by 4028.8% to $33.3 million in 2024, then tumbled by 80.45% to $6.5 million in 2025, then increased by 9.74% to $7.1 million in 2026.
• Business Quant data shows HURA's Cash from Financing Activities at $7.1 million in Q1 2026, $6.5 million in Q4 2025, and $5.3 million in Q3 2025.